Han et al.
C31H24F18N4PTa‚(0.5 C7H8): C, 39.34; H, 2.7; N, 5.32. Found: C,
39.71; H, 3.30; N, 5.29.
trans-RhCl(CO)(1a)2 (6a). A solution of 1a (60.8 mg, 0.08
mmol) in 0.4 mL of CD2Cl2 was added to [RhCl(CO)2]2 (7.8 mg,
0.02 mmol) in 0.4 mL of CD2Cl2. Gas evolution was observed,
and the solution turned dark orange over the course of 20 min. 1H
NMR (CD2Cl2, 300 MHz, 298 K): δ 3.1 (s, 6H, PCH2), 4.82 (s,
3H, NH), 7.05 (s, 6H, Ph o-H), 7.24 (s, 3H, Ph p-H). 13C{1H}
NMR (CD2Cl2, 125.8 MHz, 298 K): δ 39.1 (s, PCH2), 112.8 (s,
CO), 113.2 and 122.1 (s, Ph o-C and m-C), 118.5 (s, Ph p-C),
132.9 (q, J ) 33.1 Hz, PhC-F3), 148.9 (s, ipso-C). 31P{1H} NMR
(CD2Cl2, 121.5 MHz, 298 K): δ 22.6 (d, JPRh ) 120.1 Hz). 19F-
{1H} NMR (CD2Cl2, 282.1 MHz, 298 K): δ 14.00 (s). IR: 1984.9
P(CH2NPh)3TadNtBu (3b). Prepared in an analogous manner
to 3a using (Et2N)3TadNtBu (234.3 mg, 0.5 mmol) and 1b (173
mg, 0.5 mmol). Yield 389 mg (65%). 1H NMR (C6D6, 500.1 MHz,
298 K): δ 1.62 (s, 9H, TadNCMe3), 3.67 (d, 6H, 2JPH ) 7.3 Hz,
3
3
PCH2), 6.90 (t, 6H, JHH ) 7.3 Hz, Ph o-H), 7.27 (t, 3H, JHH
)
7.8 Hz, Ph p-H), 7.40 (m, 6H, Ph m-H). 13C{1H} NMR (C6D6,
125.8 MHz, 298 K): δ 33.8 (s, TadNCMe3), 42.6 (d, JPC ) 26.8
Hz, PCH2), 69.1 (s, TadNCMe3), 119.1 and 129.1 (s, Ph o-C and
m-C), 121.5 (s, Ph p-C), 152.3 (s, ipso-C). 31P{1H} NMR (C6D6,
202.5 MHz, 298 K): δ -100.9 (s). Anal. Calcd for C25H30N4PTa:
fw 598.45. C, 50.17; H, 5.05; N, 9.36. Found: C, 50.65; H, 5.25;
N, 9.01.
cm-1
.
trans-RhCl(CO)(1b)2 (6b). A solution of 28.0 mg (0.08 mmol)
of 1b in 0.4 mL of CD2Cl2 was added to [RhCl(CO)2]2 (7.8 mg,
0.02 mmol) in 0.4 mL of CD2Cl2. 1H NMR (CD2Cl2, 300.1 MHz,
298 K): δ 3.95 (s, 6H, PCH2), 4.28 (b, 3H, NH), 6.78 (m, 6H, Ph
o-H), 7.20 (t, 3H, Ph p-H), 7.35 (s, 6H, Ph m-H). 13C{1H} NMR
(CD2Cl2, 125.8 MHz, 298 K): δ 39.7 (t, JPC ) 14.5 Hz, PCH2),
114.2 (s, CO), 119.3 and 129.9 (s, Ph o-C and m-C), 128.8 (s, Ph
p-C), 148.2 (m, ipso-C). 31P{1H} NMR (CD2Cl2, 202.5 MHz, 298
P(CH2NArMe)3TadNtBu (3c). Prepared in an analogous manner
to 3a using (Et2N)3TadNtBu (234.3 mg, 0.5 mmol) and 1c (215
mg, 0.5 mmol) and a reaction time of 72 h. Yield 204.6 mg (60%).
X-ray-quality crystals were obtained from slow evaporation of the
1
benzene solution. H NMR (C6D6, 300 MHz, 298 K): δ 1.71 (s,
2
9H, TadNCMe3), 2.32 (s, 18H, ArCH3), 3.73 (d, JPH ) 6.7 Hz,
K): δ 23.7 (d, JPRh ) 118.1 Hz). IR: 1976.3 cm-1
.
6H, PCH2), 6.61 (s, 6H, o-H), 7.11 (s, 3H, p-H). 13C{1H} NMR
(C6D6, 125.8 MHz, 298 K): δ21.9 (s, ArCH3), 33.6 (s, 9H, Tad
NCMe3), 42.7 (d, JPC )26.3 Hz, NMe2), 68.9 (s, TadNCMe3),
116.2 (s, Ph o-C), 117.9 (s, Ph m-C), 138.7 (s, Ph p-C), 152.5(s,
ipso-C). 31P{1H} NMR (C6D6, 202.5 MHz, 298 K): δ -100.1 (s).
Anal. Calcd for C31H42N4PTa: fw 682.61. C, 54.55; H, 6.20; N,
8.21. Found: C, 54.07; H, 6.11; N, 8.77.
trans-RhCl(CO)(1c)2 (6c). A solution of 1c (34.4 mg, 0.08
mmol) in 0.4 mL of CD2Cl2 was added to[RhCl(CO)2]2 (7.8 mg,
1
0.02 mmol) in 0.4 mL of CD2Cl2. H NMR (CD2Cl2, 300 MHz,
298 K): δ 2.20 (s, 18H, PhCH3), 3.93 (s, 6H, PCH2), 4.24 (b, 3H,
NH), 6.32 (s, 6H, Ph o-H), 6.43 (s, 3H, Ph p-H). 13C{1H} NMR
(CD2Cl2, 125.8 MHz, 298 K): δ21.7 (s, PhCH3), 39.6 (t, JPC
)
(CO)3Ni(PCH2NArMe)3TiNMe2 (4). Excess Ni(CO)4 was vacuum-
transferred onto a solution of 2c (1.25 g, 2.87 mmol) in 50 mL of
toluene. The dark red solution was stirred 5 min and then evaporated
to dryness to provide a dark red product (1.77 g, 93%). The product
was stable for short durations in CH2Cl2, as judged by 31P{1H}
NMR spectroscopy, and the IR spectrum of a 0.05 M solution was
obtained in this solvent. Solutions kept at room temperature are
not stable and gradually undergo ligand redistribution with loss of
13.4 Hz, PCH2), 116.0 (s, CO), 112.0 and 121.2 (s, Ph o-C and
m-C), 139.6 (s, Ph p-C), 148.3 (t, ipso-C). 31P{1H} NMR (CD2-
Cl2, 121.5 MHz, 298 K): δ 23.5 (d, JPRh ) 116.9 Hz). IR: 1973.2
cm-1
.
trans-RhCl(CO)(2a)2 (7a). A solution of 2a (64.1 mg, 0.08
mmol) in 0.4 mL of CD2Cl2 was added to [RhCl(CO)2]2 (7.8 mg,
1
0.02 mmol) in 0.4 mL of CD2Cl2. H NMR (CD2Cl2, 300 MHz,
298 K): δ 3.5 (s, 6H, NCH3), 4.8 (s, PCH2), 7.29 (s, 6H, Ph o-H),
7.54 (s, 3H, Ph p-H). 13C{1H} NMR (CD2Cl2, 125.8 MHz, 298
K): δ 42.7 (s, TiNCH3), 49.3 (s, PCH2), 115.2 (s, CO), 113.4 and
122.1 (s, Ph o-C and m-C), 117.3 (s, Ph p-C), 133.1 (q, J ) 32.8
Hz, PhC-F3), 153.2(s, ipso-C). 31P{1H} NMR (CD2Cl2, 121.5 MHz,
298 K): δ 3.8 (d, JPRh ) 130.3 Hz). 19F{1H} NMR (CD2Cl2, 282.1
1
Ni(CO)4 and thus should be handled with care. H NMR (C6D6,
500 MHz, 298 K): δ 2.17 (s, 18H, ArCH3), 3.06 (s, 6H, NMe2),
4.07 (s, 6H, PCH2), 6.46 (s, 6H, o-H), 6.52 (s, 3H, p-H). 13C{1H}
NMR (C6D6, 125.8 MHz, 298 K): δ22.0 (s, ArCH3), 42.9 (s,
NMe2), 52.5 (d, JPC ) 15.5 Hz, PCH2), 116.1, 123.6, and 139.1 (s,
MHz, 298 K): δ 14.3 (s). IR: 1988.1 cm-1
.
3
Ph o-C , m-C and p-C), 153.8 (d, JPC ) 6.9 Hz, ipso-C), 196.3
2
(d, JPC ) 1.1 Hz, Ni(CO)3). 31P{1H} NMR (C6D6, 202.5 MHz,
trans-RhCl(CO)(2b)2 (7b). A solution of 2b (35.2 mg, 0.08
mmol) in 0.4 mL of CD2Cl2 was added to 7.8 mg (0.02 mmol) of
[RhCl(CO)2]2 in 0.4 mL of CD2Cl2. 1H NMR (CD2Cl2, 300 MHz,
298 K): δ 4.1 (s). Anal. Calcd for C32H39N4O3PTi: fw 665.21; C,
57.78; H, 5.91; N, 8.42. Found: C, 58.01; H, 5.94; N, 8.39. IR:
(CH2Cl2, 0.05M) 2073.7 cm-1 (s, A1), 2041.0 cm-1 (w), 2000.0
cm-1 (br, E).
3
298 K): δ 3.3 (s, 6H, TiNMe2), 4.6 (s, PCH2), 6.82 (d, 6H, JHH
) 7.8 Hz, Ph o-H), 6.89 (t, 3H, Ph p-H), 7.30 (t, 6H, Ph m-H).
13C{1H} NMR (CD2Cl2, 125.8 MHz, 298 K): δ 43.0 (s, TiNMe2),
49.7 (s, PCH2), 117.5 (s, CO), 117.7 and 129.7 (s, Ph o-Cand m-C),
121.6 (s, Ph p-C), 153.5 (m, ipso-C). 31P{1H} NMR (CD2Cl2, 202.5
(CO)2Ni[P(CH2NArMe)3TiNMe2]2 (5). Solid 1c (482.8 mg, 0.924
mmol) was added to a solution of 4 (614.9 mg, 0.924 mmol) in 50
mL of toluene. The solution was stirred for 48 h and evaporated to
dryness, and 15 mL of pentane was added. The solution was filtered
and the remaining dark red solid was rinsed with a small portion
of pentane and then dried under vacuum. The complex is slightly
soluble in pentane, and X-ray crystals were obtained by cooling a
MHz, 298 K): δ 15.7 (d, JPRh ) 125.8 Hz). IR: 1979.6 cm-1
.
trans-RhCl(CO)(2c)2 (7c). A solution of 2c (42.0 mg, 0.08
mmol) in 0.4 mL of CD2Cl2 was added to [RhCl(CO)2]2 (7.8 mg,
1
0.02 mmol) in 0.4 mL of CD2Cl2. H NMR (CD2Cl2, 300 MHz,
1
298 K): δ 2.28 (s, 18H, ArCH3), 3.26 (s, 6H, NMe2), 4.56(s, 6H,
PCH2), 6.46 (s, 6H, o-H), 6.47 (s, 3H, p-H). 13C{1H} NMR (CD2-
Cl2, 125.8 MHz, 298 K): δ21.9 (s, ArCH3), 43.3 (s, NMe2), 49.6-
(s, PCH2), 112.1 (s, CO), 115.6, 123.2, and 139.2 (s, Ph o-C , m-C
and p-C), 153.5 (s, ipso-C). 31P{1H} NMR (CD2Cl2, 202.5 MHz,
pentane solution to -40 °C. H NMR (C6D6, 500 MHz, 298 K):
δ 2.17 (s, 18H, ArCH3), 3.06 (s, 6H, NMe2), 1H NMR (C6D6, 500
MHz, 298 K): δ 2.15 (s, 18H, ArCH3), 3.12 (s, 6H, NMe2), 4.37
(s, 6H, PCH2), 6.51 (s, 3H, p-H), 6.56 (s, 6H, o-H). 13C{1H} NMR
(C6D6, 125.8 MHz, 298 K): δ 22.0 (s, ArCH3), 42.9 (s, NMe2),
54.0 (vt, JPC ) 15.5 Hz, PCH2), 116.0, 123.4, and 139.0 (s, Ph
o-C, m-Cand p-C), 153.8 (d, 3JPC ) 6.9 Hz, ipso-C), 190.0 (t, 2JPC
) 1.1 Hz, Ni(CO)3). 31P{1H} NMR (C6D6, 202.5 MHz, 298 K): δ
7.03 (s). Anal. Calcd for C60H78N8NiO2P2Ti2: fw 1159.69; C,
62.14; H, 6.78; N, 9.66. Found: C, 62.33; H, 6.96; N, 9.47.
298 K): δ 18.51 (d, JPRh ) 122.5 Hz). IR: 1974.8 cm-1
.
trans-RhCl(CO)(3a)2 (8a). A solution of 3a (80.5 mg, 0.08
mmol) in 0.4 mL of CD2Cl2 was added to 7.8 mg (0.02 mmol) of
[RhCl(CO)2]2 in 0.4 mL of CD2Cl2. 1H NMR (CD2Cl2, 300 MHz,
298 K): δ 1.59 (s, 9H, TadNCMe3), 4.90 (s, PCH2), 7.55 (s, 3H,
7444 Inorganic Chemistry, Vol. 45, No. 18, 2006